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ABSTRACT 
 
Mechanisms of Impaired Osteoblast Function During Disuse.   
(August 2003) 
Matthew Robert Allen, B.S., Alma College 
Chair of Advisory Committee: Dr. Susan A. Bloomfield 
 
 
Prolonged periods of non-weightbearing activity result in a significant loss of 
bone mass which increases the risk of fracture with the initiation of mechanical loading.  
The loss of bone mass is partially driven by declines in bone formation yet the 
mechanisms responsible for this decline are unclear.  To investigate the limitations of 
osteoblasts during disuse, marrow ablation was superimposed on hindlimb unloaded 
mice.  Marrow ablation is a useful model to study osteoblast functionality as new 
cancellous bone is rapidly formed throughout the marrow of a long bone while hindlimb 
unloading is the most common method used to produce skeletal unloading.  The specific 
hypotheses of this study were aimed at determining if changes in osteoblast 
functionality, differentiation, and/or proliferation were compromised in non-
weightbearing bone in response to a bone formation stimulus.  Additionally, the 
influence of having compromised osteoblast functionality at the time of stimulation was 
assessed in non-weightbearing bones.  Key outcome measures used to address these 
hypotheses included static and dynamic cancellous bone histomorphometry, bone 
densitometry, and real-time polymerase chain reaction (PCR) analyses of gene 
expression.  The results document similar ablation-induced increases of cancellous bone 
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in both weightbearing and unloaded animals.  Similarly, there was no influence of load 
on ablation-induced increases in cancellous bone forming surface or mineral apposition 
rate.  Unloading did significantly attenuate the ablation-induced increase in bone 
formation rate, due to reduced levels of total surface mineralization.  When osteoblast 
functionality was compromised prior to marrow ablation, bone formation rate increases 
were also attenuated in ablated animals due to reduced mineralization.  Additionally, 
increases in forming surface were attenuated as compared to unloaded animals having 
normal osteoblast function at the time of ablation.  Collectively, these data identify 
mineralization as the limiting step in new bone formation during periods of disuse.  The 
caveat, however, is that when bone formation is stimulated after a period of unloading 
sufficient to compromise osteoblast functionality, increases in osteoblast recruitment to 
the bone surface are compromised. 
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The Unknown 
As we know,  
There are known knowns. 
There are things we know we know. 
We also know  
There are known unknowns.  
That is to say  
We know there are some things  
We do not know.  
But there are also unknown unknowns,  
The ones we don’t know  
We don’t know.  
              —D.H. Rumsfeld, Feb. 12, 2002 
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CHAPTER I 
INTRODUCTION 
The relationship between mechanical loading and bone mass can be traced back 
to the pioneering theories and writings of Julius Wolf and Wilhelm Roux during the late 
nineteenth century.  Over the following decades, researchers further defined the 
influence of mechanical loading on bone structural adaptation.  In a seminal paper by 
Rubin et al., it was first documented that the skeleton adapted based on the level of 
mechanical load to which it was exposed; removal of all external load resulted in bone 
loss, while just twelve minutes per day of mechanical compression increased bone mass 
(1).  These data have served as a building block for a greater understanding of the 
relationship between mechanical load and bone adaptation, which now continues into its 
second century of study. 
In addition to the interest in mechanical loading effects on skeletal tissue, there 
are important reasons to investigate the adaptations of bone to periods of reduced 
loading.  This interest is motivated by the large number of individuals adversely affected 
by the removal of weightbearing activity through prolonged bed rest, limb 
immobilization after injury and spaceflight.  Additionally, it is believed that some of the 
underlying events that lead to unloading-induced bone loss are similar to those occurring 
with aging, with the former simply occurring on an accelerated time frame.  Therefore, 
research aimed at determining the mechanisms of disuse-induced bone loss will likely   
_______________ 
This dissertation follows the style and format of the Journal of Bone and Mineral 
Research. 
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provide insight into age-induced bone loss, which affects millions of individuals. 
Under normal weightbearing conditions, the skeleton is in a state of balance, with 
osteoblast-mediated bone formation coupled to osteoclast-mediated bone resorption.  
This results in a conservation of bone mass over time.  During periods of disuse such as 
spaceflight, this formation/resorption balance is “uncoupled”, with decreases in 
formation and increases (or no change) in resorption producing a loss of bone mass.  
Despite numerous studies confirming the decline in bone formation as a major 
contributor to unloading-induced bone loss, few studies have investigated the 
mechanisms responsible for this altered osteoblast activity.  To this end, a recent review 
of the physiological effects of long-duration spaceflight concluded that the loss of bone 
mass is “one of the most serious and intractable health risks identified so far” and that 
“at the basic science level, little is known about the fundamental mechanisms underlying 
the loss of bone mineral density in microgravity” (2).  These statements clearly show the 
need for research focused on the mechanisms of disuse-induced bone loss.   
Studying spaceflight-induced bone loss is a challenging task, as few human 
subjects are available and non-invasive measures of bone are limited in scope.  For these 
reasons, animal models have been developed, with the rodent hindlimb unloading model 
one of the best validated for the changes that occur during spaceflight (3).  This model 
produces changes in the hindlimbs similar to those that occur in both rodents and 
humans during spaceflight, including loss of bone mass and decreases in bone formation.  
Despite the abundance of descriptive data gained from the hindlimb unloaded rodent 
model with respect to skeletal adaptations, data are sparse concerning the mechanisms 
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behind the bone formation declines.  Additionally, there has yet to be a countermeasure, 
mechanical or pharmacological, that has preserved bone mass during continuous 
unloading in a mature skeleton through maintenance of bone formation, suggesting 
normal levels of osteoblast activity may not be possible in the absence of mechanical 
load.  
 The objective of this research was to investigate the limitations of new bone 
formation during mechanical unloading by superimposing the physiological stressor of 
marrow ablation on the skeletally mature tail suspended mouse.  As marrow ablation 
provides a potent bone formation stimulus, these studies were designed to determine if 
bone formation rate increases are limited during unloading because of reduced mature 
osteoblast function, disrupted osteoblast proliferation/differentiation, or a combination of 
the two.  It was hypothesized that ablation-induced bone formation would be less 
pronounced in unloaded animals due to both reduced mature osteoblast activity and 
compromised osteoblast differentiation/proliferation.   
This hypothesis was tested by quantifying bone density, bone volume, percent 
mineralizing surface, percent osteoblast surface, mineral apposition rate and bone 
formation rate to assess osteoblast functionality.  Additionally, osteoblast development 
was evaluated through quantitation of core-binding factor 1 and osteocalcin gene 
expression patterns, markers of early osteoblast differentiation and fully mature 
osteoblasts, respectively.   
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Specifically, the experiments detailed herein addressed the following hypotheses: 
1) Unloading will reduce the bone formation response to marrow ablation by 
inducing deficiencies of osteoblast functionality (osteoblast surface, 
mineralizing surface, mineral apposition rate and bone formation rate). 
2) Unloading animals for 10 days prior to ablation, so as to significantly 
compromise osteoblast functionality, will further reduce the ablation-
induced bone formation response in unloaded bones. 
3) The hypothesized attenuated osteoblast response to marrow ablation in 
the absence of mechanical load will be the result of a decrease in both 
early osteoblast differentiation and late osteoblast development.  The 
disruption of these processes will be exacerbated if osteoblast 
functionality is reduced by 10 days of unloading prior to ablation. 
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CHAPTER II 
REVIEW OF LITERATURE 
To place the current study into proper context, a brief review of previous 
literature in the field of skeletal adaptations to unloading is necessary.  This review will 
begin by providing background information on osteoblast development and function, the 
major cells of interest in this study, followed by a summary of major findings from 
human spaceflight/bed rest studies and animal spaceflight/ hindlimb unloading studies, 
with particular focus on osteoblast-related measures.  Additionally, the events that take 
place following marrow ablation will be outlined. 
   
Osteoblasts 
Osteoblasts, the bone forming cells, originate from mesechymal stem cells 
(MSC) within the bone marrow and periosteum (4-6).  These MSC repeatedly divide, 
with one of the daughter cells progressing on and the other retaining the progenitor 
capability (7).  The hallmark of stem cells, however, is that they have non-delineated 
lineages, thus having the ability to transform into various cell types (5).  The MSC have 
five known tissue lineages, which include bone, muscle, adipose, cartilage and vascular 
smooth muscle cells (5).  It is not currently known at what point in the differentiation 
process commitment to a specific lineage is absolute.   
Core-binding factor 1 (cbfa1; also known as Runx2) is a member of the runt 
homology domain transcription factor family and has been identified as the earliest 
known osteoblast differentiation marker (4,8).  It is the only known transcription factor 
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specific to cells of the osteoblast lineage, its expression being restricted to post-natal 
osteoblast precursors called osteoprogenitors (8).  The vital nature of this factor is 
displayed through studies of mice lacking cbfa1, which die within hours of birth as their 
skeleton is completely cartilaginous (8).  These mice have a complete absence of both 
endochondral and intramembranous bone formation due to the lack of functioning 
osteoblasts (8).  These data, along with others, document that cbfa1 plays a key role in 
promoting differentiation of osteoprogenitor into fully functioning osteoblasts.   
Osteoprogenitor cells, present in measurable but low numbers in mouse bone 
marrow stroma, have two distinct populations.  One of these populations appears to have 
the ability to constitutively differentiate, while the other inducible population only 
differentiates with certain stimuli (steroids or bone morphogenic proteins)(6).  Although 
the exact mechanisms by which osteoprogenitor cells become committed pre-osteoblasts 
are not clear, once commitment occurs, levels of alkaline phosphatase begin to increase 
(9).  Thereafter, pre-osteoblasts promptly proliferate, eventually becoming fully 
functioning osteoblasts.  These cells are highly enriched in alkaline phosphatase, able to 
secrete type I collagen and bone matrix proteins, and express high levels of osteocalcin.  
Prior to the identification of cbfa1, osteocalcin was the only known osteoblast-specific 
gene (8).  It is expressed only in post-proliferative osteoblasts which are fully mature, 
normally during mineralization of organic matrix (8,10).  
A limited number of studies have examined changes in osteoblast cells in 
response to unloading, utilizing cells cultured in space or in various rotating cell culture 
systems (11).  When cultured in space, two different osteoblast cell lines had a reduced 
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total cell number and altered cell morphology compared to ground control cultures (12).  
After one day of culture, osteoblasts had reduced mRNA expression of both early 
growth genes and osteocalcin, suggesting these cells are slower to enter the cell cycle in 
microgravity and have reduced ability to become fully functioning cells (13).  When 
cultures were treated with 1,25D and TGF-β to stimulate rapid osteoblast development, 
spaceflight cultured cells had lower c-fos, alkaline phosphatase and osteocalcin mRNA 
(14-17).  Collectivity, these reductions indicate a decrease in both differentiation and 
proliferation.  Similarly, previous studies utilizing various forms of rotating vessels, used 
to effectively unload cultured osteoblasts on Earth, have documented decreases in 
alkaline phosphatase, collagen 1α (I), osteocalcin and cbfa1 mRNA compared to 
controls.  Results were similar both with (18) and without stimulation with 1,25-
dihydroxyvitamin D3 (1,25-D)(19).  Reductions in total cell number and an increase in 
apoptotic cell number have also been quantified in rotating culture experiments (20). 
In summary, the pathway from mesechymal stem cell to functioning osteoblast is 
a complex process which is just beginning to be elucidated.  A pivotal finding in 
advancing this process was the identification of core-binding factor 1 (cbfa1), the earliest 
known osteoblast-specific transcription factor and key regulator of osteoblast 
differentiation.  Quantification of cbfa1 and osteocalcin, a marker of mature osteoblasts, 
provides a reliable means of studying osteoblast-specific mechanisms relevant to various 
skeletal-related perturbations, including disuse.  
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Human Disuse Studies: Bed Rest 
Bed rest provides a unique Earth-based model to study the effect of microgravity 
on the skeleton, as it eliminates the ground reaction forces that the bones of the lower 
limbs normally experience during ambulation.  Therefore, the only direct strain on the 
lower limb bones is from voluntary muscle contractions, similar to what occurs during 
spaceflight.  As subjects for these studies are healthy volunteers, the adaptations are the 
result of disuse, not some underlying pathology.  The majority of data on the adaptations 
of the human skeleton to disuse have been derived from these bed rest studies with 
measures of calcium balance, bone mineral content and density, serum and urine 
markers of bone formation/resorption, and histological measures of both cortical and 
cancellous bone.   
The most commonly studied parameter during bed rest is calcium excretion, 
often reported as daily urine (and sometimes feces) output.  As the skeleton is the major 
store of calcium in the body, increased calcium excretion without significant changes in 
dietary intake is usually interpreted as loss of skeletal mineral although it is important 
that both urine and fecal excretion be measured to determine total calcium excretion as 
offsetting changes could occur resulting in no net change.  Increased output has been 
quantified after two days of bed rest (21,22), reaching levels 40% higher than baseline 
after one week (23).  The majority of studies suggest calcium excretion peaks after 3 to 7 
weeks of disuse, reaching between 21-300% higher than baseline (22,24-28) with an 
apparent plateau thereafter, even as far out as 9 months (25).  This degree of increased 
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calcium excretion is substantial, ranging from 100 to 200 mg/day or 0.5 to 1.3% of total 
body calcium per month (22,24,25).   
Changes in bone mineral content, assessed by various absorptiometry and 
densitometry techniques, have generally agreed with calcium excretion data.  One study 
demonstrated that total body mineral loss (-0.08% per week) closely corresponded to 
total calcium excretion (-0.1% per week)(29).  Regional loss of mineral content and 
density of the femoral neck, greater trochanter, tibia and lumbar spine range from 0.1 to 
0.5% per week after 17 weeks of bed rest (27,29-31).  The calcaneus, a bone of the foot 
that experiences the highest loads during normal ambulation, appear to be most severely 
affected by disuse with loss of bone mineral content averaging 1.5% per week 
(25,29,32).   
Analysis of serum and urine biomarkers provides information regarding systemic 
changes in bone formation and resorption.  Markers of bone formation are produced by 
osteoblasts as they lay down osteoid, while resorption markers are components of bone 
inorganic matrix that are released as during bone resorption.   Urine markers of bone 
resorption are consistently elevated with bed rest (23,25,26,28,33-37).  Significant 
increases have been quantified by day 4 (23) and reach levels 70 to 200% higher than 
baseline after 10 to 14 weeks (26,35).  Osteocalcin, one of only two bone-specific 
proteins produced by osteoblasts, is the most commonly studied marker of bone 
formation.  Data are inconclusive with respect to bone formation biomarkers, as studies 
have quantified both decreases (26,35) and no difference (23,27,33,37) in serum 
osteocalcin compared to baseline levels after various durations of bed rest.    
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Few studies have utilized histology to quantify the effects of bed rest on localized 
bone activity, as this requires invasive bone biopsies.  After twelve-weeks of bed rest, 
iliac crest cancellous bone resorption surface is increased and cancellous bone osteoblast 
surface decreased compared to baseline measures; there is no significant change in 
cancellous bone volume, mineralizing surface, mineral apposition rate or bone formation 
rate (27).  Longer duration bed rest (17 weeks) also produces no change in iliac crest 
cancellous bone volume compared to baseline, but trabecular number, mineral 
apposition rate and osteoblast surface are all reduced compared to baseline values 
(38,39).   
In summary, data from human bed rest studies conclusively quantify rapid and 
substantial increases in calcium excretion, leading to decrements in bone mineral content 
and density.  These changes in mineral and density appear to be most prevalent in 
cancellous bone, particularly at locations that normally experience high levels of 
mechanical loading.  The etiology of these changes, however, is not yet well-defined due 
to the limited number of studies.  Both whole body biomarker and iliac crest histological 
analyses document increases in bone resorption while some, but not all studies, 
demonstrate decreases in bone formation. 
 
Human Disuse Studies: Spaceflight 
 Data from early bed rest studies, coupled with calcium excretion changes from 
the first Gemini flight, suggested that significant bone mineral loss (0.7 to 1.3% per 
month) would occur during spaceflight (40).  Subsequent data from short term (5 to 18 
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day) Gemini and Apollo missions quantified bone loss of the os calcis ranging from 0-
9% (41-43) accompanied by increases in urine and fecal calcium (44).  As the 
radiographic techniques used to assess bone mineral in these studies have relatively low 
precision, the accuracy of conclusions based on these data has been questioned (43). 
With the 1973 launch of Skylab, the first permanent inhabitable space station, 
followed later by Salyut-6 in 1977 and MIR in 1986, a platform for biomedical research 
in space was established.  Increases of urinary calcium were quantified after one day of 
spaceflight, reaching levels 80-200% higher than preflight values after one month 
(41,45,46).  Markers of bone resorption significantly increased after one week of flight, 
with levels reaching 100-200% above preflight values (36,46,47).  Bone formation 
biomarkers were 30% lower compared to pre-flight values (47).  Bone mineral content, 
measured pre- and post-flight using the more sensitive dual energy x-ray absorptiometry 
(DEXA), declined by 1 to 1.6% per month at the spine, femoral neck, trochanter, pelvis, 
and calcaneus; whole body mineral content loss averaged 0.3 to 0.4% per month (48).  
More sophisticated analyses, using computed tomography techniques, focusing on 
changes in cancellous bone density of the distal tibia, quantified reductions of 1.8 to 
5.4% after six months of flight (49,50). 
In summary, relatively few studies have assessed skeletal adaptations to 
spaceflight in humans.  This makes global conclusions difficult, although it is clear that, 
similar to bed rest, bone mineral loss occurs rapidly and is significant in magnitude.  The 
result of this mineral loss is reduced bone density, with the cancellous bone 
compartment of weightbearing bones most severely affected.  The etiology for these 
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changes is not clear, with even fewer data than bed rest studies.  Changes in biomarkers 
of bone formation and resorption mimic those from bed rest with no histological data 
published to date. 
 
Animal Disuse Studies: Spaceflight 
Although studies on human adaptations in space provide the most useful data, 
limitations with respect to subject numbers and types of studies that can be performed 
in-flight make conclusions difficult to draw.  Thus, most of what we have learned about 
spaceflight-induced adaptations is derived from animal studies of both primates and 
rodents, with the former providing data that are more applicable to humans, although 
they are almost as rare. 
Non-human primate spaceflight studies, while only short-term (9 to 14 days) and 
with few subjects (1 to 2 per mission), provide valuable data due to the invasive 
measures that are possible.  Decreases in bone mineral density range from -1.7 to -17% 
depending on the anatomical site (51,52) in skeletally mature animals.  One additional 
study concluded that space flown monkeys failed to gain bone density as measured in 
ground controls, likely a function of studying younger animals still accruing bone mass 
(53).   
Iliac crest cancellous bone volume of space flown monkeys is significantly lower 
than that in ground controls, accounted for by decreases in trabecular thickness with no 
change in trabecular number (52,54).  Additionally, osteoblast surface, osteoid thickness, 
mineralizing surface, mineral apposition rate and bone formation rate in iliac cancellous 
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bone are all significantly lower compared to controls (52,54).  Serum measures of 
alkaline phosphatase (55) and osteocalcin (56), markers of osteoblast activity, are also 
lower compared to control values.  Additionally, in vitro studies of marrow cells taken 
from flight monkeys reveal decreased mineralization (52,56), osteoblast proliferation 
(54,56) and osteoblast differentiation (57).      
The most abundant spaceflight animal data is derived from rodents, particularly 
rats.  It is important to note, however, that nearly all rodent studies during spaceflight 
have utilized relatively young (less than three-month-old) animals, making interpretation 
difficult as a large part of the unloading effect is an attenuation of growth.  This growth 
attenuation is manifested in bone through alterations of modeling, rather than alterations 
of remodeling, as would occur in skeletally mature bone.     
The earliest rodent spaceflight study, a 22-day mission aboard Cosmos-605, used 
light and electron microscopy to qualitatively document significant metaphyseal bone 
loss compared to controls (58).  Subsequent quantitative studies have confirmed these 
observations, documenting lower cancellous bone volume of the proximal tibia (59-62), 
humerus (60,63), vertebrae (62) and pelvic bone (64) in space flown rats compared to 
ground controls.  Some studies, however, have found no changes with unloading in bone 
volume of the vertebrae (63,65), humerus (65,66) and femur  (61,62) compared to 
controls.  In those studies that did quantify altered bone volume, both trabecular thinning 
(61,64) and lower trabecular number (59,63) accounted for the reductions.   
Despite the apparent discrepancy of changes in bone volume, osteoblast-related 
parameters are consistently reduced in skeletally immature rats during spaceflight.  
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Cancellous bone osteoblast surface is reduced, compared to ground-based controls, in 
the tibia (60-62), vertebrae (62,63,65), femur (62), humeri (63,66) and pelvis (64).  
Interestingly, decreases in osteoblast surface are also observed in the mandible, a non-
weightbearing bone, suggesting that spaceflight may have effects on osteoblast cells 
independent of changes in mechanical load (67).  Accompanying these changes in 
osteoblast bone surface are decreases in mineral apposition rate and bone formation rate 
(64,66), indicating reduced functional capacity of those osteoblasts which still existed 
and/or reduced number of active surfaces.  Gene expression data support these findings 
as both osteocalcin and type I collagen mRNA expression are reduced in metaphyseal 
bone post-flight compared to ground controls (68,69).  Indices of resorption, osteoclast 
number and/or eroded surfaces are not significantly different from ground controls at 
metaphyseal bone sites (60,62,66). 
In summary, primate and rodent spaceflight data document reductions of 
cancellous bone volume at multiple sites.  Serum biomarkers, cancellous bone histology, 
gene expression and marrow cell culture data have all quantified significant decreases in 
various osteoblast parameters (number, activity, proliferation and differentiation).  To 
date, no studies have documented changes in osteoclast histological parameters.  It is 
important to note, however, that most published data are based on immature skeletons 
and do not necessarily reflect adaptations that may occur in mature skeletons.  
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Animal Disuse Studies: Hindlimb Unloading Model 
During the mid-1970s, in the midst of the Cosmos space missions, the need for 
an Earth-based model to simulate microgravity in animals became clear as the number of 
animals that could be flown on missions was (and remains) very limited.  The criteria for 
an acceptable model were five-fold: allow ambulation using only the forelimbs; unload 
the hindlimbs without paralysis or rigid immobilization; produce cephalic fluid shifts; 
allow normal eating, drinking, and grooming; and produce minimal stress.  The tail 
suspended rat model as developed by Emily Morey-Holton met all necessary criteria 
(70).  Early 20-day experiments in young rats resulted in significant reductions in tibial 
cortical bone formation similar to those observed after 20 days of spaceflight on Cosmos 
missions suggesting it was an acceptable model for studying skeletal adaptations to 
unloading (70).  Since this early study, the model has taken many forms, both in name 
(simulated weightlessness, tail suspension, hindlimb unloading, etc.) and details of the 
harnessing system design.  By late 2002, it had become the standard rodent model to 
study adaptations to microgravity, with over 800 publications covering numerous 
physiological systems (3). 
When assessing the rodent hindlimb unloading literature, there is unfortunately 
little standardization among studies in regard to animal age, duration of unloading, site 
of analysis and the type of assessment.  Despite these differences, some generalizations 
can still be made from the data.  An overwhelming number of studies utilized one- to 
three-month-old animals, an age of rapid bone growth, and maintain unloading for 3 to 
24 days, depending on the outcome measure of interest.  The most common skeletal sites 
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studied in young rats have been the proximal and mid-diaphyseal tibia, proximal, mid-
diaphyseal, and distal femur and vertebrae.  Early studies used relatively simple 
analyses, such as measures of whole bone mass, while recent studies have progressed to 
utilize micro-computed tomography (microCT) and gene expression analyses.  
Histomorphometry, however, has remained the gold standard, providing the most data 
over the years with regard to cellular adaptations to unloading.   
Whole tibial bone mass is significantly lower than weightbearing controls after 7 
to 14 days of unloading (71-73).  Beyond this time period, however, bone mass accrual 
occurs at rates similar to control animals, suggesting simply an acute attenuation of 
growth during unloading, with an eventual return to normal rates (71).  Changes in 
calcium content mimic those of total bone mass, with decrements in tibia and vertebrae 
calcium content observed at both 7 and 14 days (71,74,75).  Regional changes, however, 
differ from whole bone measures, with proximal tibia continuing to lose bone density 
over three weeks (76).  Changes in skeletal calcium uptake and matrix accretion, 
assumed to reflect osteoblast activity, mimic those of bone mass as they are significantly 
reduced after 5 days of unloading and return to control values by days 10 to 15 (71,74).  
Proximal tibia cancellous bone volume is similar to weightbearing controls after 
4 to 5 days of unloading (77,78).  Significant reductions are detectable by day 6 (79) 
with a continued depression compared to controls through day 14 (72,75,76,80).  This 
lower bone volume is accounted for by decreased trabecular thickness (72,75,79) and 
trabecular number (75).  Mineral apposition and formation rates of proximal tibia 
cancellous bone are lower compared to controls after 4 to 8 days (73,76-78, 80), 
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although mineral apposition rate returns to control levels around day 14 (75,76,80).  
Measures of osteoblast and osteoid bone surface are reduced compared to controls after 
just 4 days of unloading (77) and remain lower through 14 days (73,75,78,79,81).  
Measures of resorption such as osteoclast/eroded bone surface are not different in 
unloaded cancellous bone compared to controls (75,76,79,80).   
Short-term studies, designed to assess changes of gene expression, consistently 
document reductions of osteoblast markers.  After five days of unloading, osteocalcin 
mRNA is significantly reduced (68) while by day 7 to 8, Cbfa1, osteocalcin and collagen 
Iα mRNA expressions are at non-detectible levels (77).   Alkaline phosphatase mRNA 
expression also progressively decreases through 14 days of unloading (68).  Collectively, 
these data suggest a retardation of osteoblast maturation with unloading. 
A limited number of studies have also examined cellular composition of bone 
tissues after unloading, with data suggesting reductions in osteoblast progenitor cells.  
After 6 days of unloading, both proximal tibia metaphysis and marrow cavity reveal 
80% fewer preosteoblasts compared to controls (79).   Detailed study of proximal tibia 
primary spongiosa, a highly cellular portion of the bone rarely studied due to its lack of 
mineralized tissue, documented a reduction in differentiated osteoprogenitor cells and 
fewer pre-osteoblasts (82).  These data suggest a reduced differentiation and 
proliferative capacity of osteoprogenitor cells during unloading.  
Cell cultures of marrow harvested from unloaded rats provide additional data 
with regard to changes in cell development/function.  Following 2 to 5 days of 
unloading, cell culture mineralization is reduced coupled with a reduction in overall cell 
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proliferation, alkaline phosphatase and c-fos mRNA production (83).  Longer periods of 
unloading yield similar results: reduced expression of osteocalcin (83) and alkaline 
phosphatase (78, 84), mineralizing colonies (78), and total number of cells (84) as 
compared to those in control rat marrow cultures.   
While the above data provide pivotal information with regard to changes in the 
unloaded skeleton, the use of animals that are still undergoing rapid bone growth make 
interpretation difficult.  Do reduced bone density and volume compared to ground 
controls really reflect bone loss, or simply a lack of bone gain during growth?  This 
question is substantiated by the finding that bone mass accrual in young unloaded rats 
proceeds at similar rates as controls after 7 to 14 days of unloading, and mineral 
apposition rate returns to control levels during a similar time frame.  Therefore, it is 
useful to eliminate the effects of growth by studying skeletally mature animals during 
unloading.  Although the rat continues to slowly increase body mass throughout its life, 
the rate of skeletal growth slows significantly after 5 months of age (85).   More recently 
published studies have used skeletally mature rats and reveal distinct differences 
compared to young, growing rats.  
Five-month-old rats exhibit reduced proximal tibia cancellous osteoblast surface 
(86) despite no change in bone volume after just one week of unloading; by day 14, 
tibial mineral content and density are significantly lower than controls (87).  Unloading 
for longer durations, 28 to 40 days, results in significant reductions in cancellous bone 
volume (80) and bone density (88).  Additionally, mineral apposition rate, mineralized 
surface and osteoblast surface are reduced compared to weightbearing controls with no 
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difference in osteoclast surface (86,89).  These prolonged decrements in bone formation 
(through 35 days) are in direct contrast to the transient (7- to 14-day) reductions 
quantified in skeletally immature animals.  
Hindlimb unloading studies have also been carried out using mice, a species that 
provides certain advantages over the rat model, such as the potential to use genetically 
modified strains (90,91).  Interpretation of mouse data, however, must be carefully 
considered, as there is a significant effect of genetic background on the skeleton (92).  
Studies of 12-month-old female mice from multiple genetic strains reveal that the 
C3H/HeJ (C3H) strain has a 50% higher total femoral density compared to the 
C57BL/6J (B6) mouse, which has the lowest density of those strains examined (92).  
Additional analyses of these two strains quantified differences in distal femur cancellous 
bone volume at four months (93) yet cancellous osteoid surface, mineral apposition rate 
and bone formation rate were similar (93). 
The most common genetic background used in bone-related hindlimb unloading 
studies is the B6, “low-density” mouse (94-100), although data do exist from the C3H, 
“high-density” mouse.  Following 21 days of unloading, four-month-old female C3H 
mice exhibit non-significantly lower proximal tibia bone volume, mineral apposition rate 
and bone formation rate (-31, -6 and -39%, respectively) compared to baseline controls 
(100).  Similar age C3H male mice, suspended for 14 to 21 days, exhibited no change in 
bone volume or mineral apposition rate compared to control (97), suggesting a within-
strain gender difference in the bone response to unloading. 
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In summary, data from hindlimb unloaded rodent models reveal changes similar 
to those observed in space flown rodents.  Cancellous bone is most severely affected due 
to significant decrements in osteoblast development and function, whereas resorption 
parameters are not significantly different.  Skeletally mature animals have been studied 
during ground-based hindlimb unloading, and have generally confirmed decreases in 
cancellous bone volume and density, osteoblast surface and bone formation rate with no 
change in osteoclast parameters.  One fundamental age-dependent difference, however, 
is that young animals have only transiently lower mineral apposition rate, bone 
formation rate and bone mass accrual, while skeletally mature animals have continued 
depression of these values through 35 days of mechanical unloading. 
 
Marrow Ablation as a Bone Formation Stimulus 
 Since the 1960’s, research concerning long bone marrow regeneration has been 
undertaken, often as it relates to local tissue injury.  Early studies provided much of what 
is currently known regarding the series of events that follow removal or disruption of 
marrow from long bones (101,102).  These early studies speculated that the disruption of 
the continuum of marrow stroma initiated these processes, as disruption without removal 
(ablation) of marrow produced similar results.  Subsequent research in both rats and 
mice has helped define the sequence of events that follow marrow ablation, with no 
notable differences identified between the two species (for summary of key ablation 
related skeletal events see Figure 1).   
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Clot formation/retraction, capillary invasion,
blood flow resumed
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5 First signs of mineralized tissue in marrow cavity
Cancellous bone with ample osteoid
Increased osteoblast number
Increased BV/TV
Marrow cavity completely filled with cancellous
tissue
Days post 
ablation
 
 
FIG. 1.  Timeline of significant events during the “osteogenic period” following marrow 
ablation.  These results are derived from both rat and mouse studies (103-106,108). 
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Immediately following marrow ablation, a blood clot fills the marrow cavity and 
then retracts soon afterward, allowing reformation of the marrow cavity blood vessel 
network (103).  This allows resumption of blood flow, providing a means through which 
cells (thought to be pre-osteoblasts) from the surrounding cortical bone can migrate to 
the marrow cavity.  These cells, along with stromal cells remaining after ablation (e.g. 
attached to endocortical surface, among trabeculae), play the largest role in marrow 
regeneration.  It is important to note that these stromal cells have little migratory 
potential, with no evidence of movement from the epiphyses to other under-populated 
areas (102).  By day 3, a rudimentary trabecular network with faint signs of 
mineralization has formed (103) and osteoblasts begin proliferating and forming osteoid.  
Osteoblast-lined trabecular bone, growing out from the endocortical surface, is observed 
by 6 days post-ablation, increasing in volume by day 8 (103).  By this time, mineral 
apposition rate, osteoid volume and osteoblast surface have increased substantially 
compared to untreated controls (104).   Bone formation rate and bone volume peak 
between days 6 and 14 (103,105,106).  There is no significant change in bone resorption 
parameters refuting an increased turnover argument (104,107).  This “trabecularization” 
of the marrow cavity is vital, as without it neither increased bone formation nor marrow 
regeneration occur.  Soon after this peak bone volume is attained, marrow sinusoids 
develop, allowing marrow cells to repopulate the cavity.  Increases in osteoclast number 
then occur, which eventually resorb the majority of the newly formed cancellous bone.  
Full marrow regeneration is complete by 20 to 30 days after ablation, with all surfaces 
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having osteoblast-related parameter values (bone volume and formation rate) 
comparable to non-ablated controls (103).   
Molecular biology studies have provided insight into the mechanisms of these 
responses to marrow ablation.  By day 5 after ablation, alkaline phosphatase mRNA is 
significantly elevated four-to-five fold (103,105,108); osteocalcin expression is similarly 
elevated by day 6 (103,105,106).  In situ hybridization (109) and in vivo real-time 
bioluminescence (110) have also quantified significant increases in osteocalcin mRNA 
within the first week post-ablation.  Levels of pro-collagen α (I) mRNA reached 
maximum levels by day 6 (103,105), with α (II) and α (III) levels unchanged (103).  As 
levels of pro-collagen α (II) mRNA expression often increase in response to fracture 
injury, this suggests the deposition of bone following ablation is different from callus 
formation after fracture, another example of rapid bone formation (105).  The early rise 
in alkaline phosphate and pro-collagen α (I) mRNA expression reflect increases in 
preosteoblasts and proliferating osteoblasts, while later increases in osteocalcin mRNA 
suggests increased numbers or activity of mature osteoblasts (105).  
In summary, marrow ablation results in a well-defined series of events 
highlighted by a significant increase in osteoblast and bone formation parameters 7 to 14 
days post-ablation (Figure 1).  These parameters have been quantified by numerous 
methods including histology, densitometry and gene expression.  While the majority of 
marrow ablation studies have utilized rats, the few that have quantified responses in 
mice reveal no differences with respect to temporal and qualitative events.  Although the 
specific mechanism of marrow trabecularization in response to ablation are not known, 
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most data suggest that local stromal cells remaining on trabeculae and endocortical 
surfaces, along with pre-osteoblasts arriving through the circulation, play a significant 
role through differentiation and proliferation into osteoblasts. 
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CHAPTER III 
   RESEARCH 
During prolonged periods of non-weightbearing activity, such as bed rest, 
immobilization and spaceflight, weightbearing bones experience significant loss of bone 
mineral (1 to 2% per month) (29,49,50).  Human serum and urine biomarker data 
suggest that changes in both bone formation and resorption contribute to disuse-induced 
bone loss, as bone resorption markers are consistently increased (26,35,36,46,47) and 
bone formation markers are consistently decreased (26,35,47).  Histology data on bone 
biopsies from bed rest subjects, which directly assess localized tissue level changes at 
the iliac crest, suggest that bone formation changes to a greater degree than does 
resorption.  Significant decreases in osteoblast surface (27,38,39) and mineral apposition 
rate (38,39) in these subjects are accompanied by minimal changes in osteoclast surface 
(27).       
Due to the limitations of studying disuse-induced changes in humans, particularly 
during spaceflight, the rodent hindlimb unloading (HU) model was developed.  This 
model has been used extensively to study physiological adaptations of many tissues to 
spaceflight, including the skeleton (3,70). In skeletally immature rats (1- to 3-months-
old), hindlimb unloading produces significant depressions in cancellous bone formation 
rate and increases in bone resorption.  However, these changes return to control levels 
after 14 days, suggesting only transient perturbations of bone turnover in unloaded, 
growing animals (71,74).  Studies on skeletally mature rats (> 5 months old) have also 
documented significant decrements in cancellous bone mineral density, mineralizing 
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surface, osteoblast surface and bone formation rate with unloading; however, these 
changes persist through 28-35 days of unloading (86,88).  Additionally, there is no 
change in cancellous bone osteoclast/eroded surfaces (86).  Unloading-induced 
reductions in cancellous bone volume (97,100,111) and bone formation rate 
(97,100,111) have also been documented in skeletally mature mice after 14 to 28 days.   
Few studies to date have investigated the underlying mechanisms responsible for 
decreased osteoblast activity during disuse.  Cultures of marrow from unloaded long 
bone (78,83) and of osteoblasts grown in unloaded environments (13,19) suggest 
decrements in proliferation and differentiation.  Another indirect method used to 
elucidate mechanisms is through application of various countermeasures.  Both 
mechanical and pharmacological interventions have had variable success with respect to 
bone parameters (mass/density), yet no study to date has documented maintenance of 
bone formation rate in continuously unloaded skeletally mature animals.  It is therefore 
unclear whether disuse-induced declines in osteoblast functionality can be attenuated in 
a mature skeleton.   
Marrow ablation (removal of the marrow from a long bone) results in a rapid 
formation of cancellous bone throughout the entire marrow cavity (103).  Once this 
cancellous scaffolding has been provided, marrow regeneration proceeds, after which the 
bone scaffold is resorbed.  This experimental model is unique in that the cancellous bone 
formation follows a well-defined series of events, highlighted by a significant increase in 
bone formation parameters including osteoblast surface and bone formation rate.  Within 
days of ablation, localized osteocalcin gene expression (103,106,108) and bone 
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formation rate (104,106) are significantly increased while by day 7 to 14 cancellous 
bone has filled a majority of the marrow cavity.  Due to the potent and rapid osteoblast-
stimulating effect of marrow ablation, it may serve as an excellent model with which to 
study the effects of hindlimb unloading on osteoblast differentiation, proliferation and 
function.   
Therefore, the research described herein was designed to investigate the 
limitations of bone formation during unloading by superimposing the physiological 
stressor of marrow ablation on the hindlimb unloaded mouse.  Specifically, the 
following hypotheses were tested:  1) ablation-induced increases in osteoblast 
functionality will be reduced in unloaded mice compared to weightbearing controls, 2) 
unloading for 10 days prior to ablation, so as to compromise osteoblast functionality, 
will further reduce the osteoblast response to marrow ablation in unloaded bone, 3) the 
reduced osteoblast response to ablation in unloaded bone will be the result of a decrease 
in both differentiation and proliferation.  Key outcome measures used to address these 
hypotheses included static and dynamic cancellous bone histomorphometry, bone 
densitometry by peripheral quantitative computed tomography (pQCT), and real-time 
PCR analyses of gene expression. 
Methods 
The following study protocols and all animal procedures were in compliance 
with the Texas A&M University Laboratory Animal Care Committee rules and 
regulations. 
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Study one.  Four-month old C3H/HeJ (C3H) male mice from Harlan (Indianapolis, IN) 
were housed individually in a temperature-controlled room (21 ± 2°C) with a 12:12 hour 
light/dark cycle and provided free access to standard chow and water throughout the 
experiment.  Preliminary studies revealed a significant increase in bone volume in 
response to ablation in this age/strain mouse.  One week after arrival, mice were 
randomly assigned into treatment groups (n=6-8 per group):  baseline control (BC), cage 
control + marrow ablation (CCAB), hindlimb unloaded (HU), and hindlimb unloaded + 
marrow ablation (see Table 1 for experimental outline).  The hindlimb unloaded + 
marrow ablation animals were further divided into two groups (n=6-8 per group) which 
differed by when marrow ablation was performed.  One group underwent ablation on the 
day of unloading (HUAB) while the other was unloaded for 10 days prior to ablation 
(HU10AB).  Groups of animals were sacrificed at two separate time points, 10 and 14 
days post-ablation, both falling within the osteogenic period (Figure 1)(103,104,106), in 
the event that unloading delayed bone formation responses.    
On day 0, all animals were anesthetized (0.33mg/kg fentanyl citrate, 16.7 mg/kg 
droperidol, and 5.0 mg/kg diazepam) and underwent right femur marrow ablation and/or 
hindlimb unloading.  When ablations were performed on animals after 10 days of 
unloading, animals were completely anesthetized before removal from suspension to 
avoid any weightbearing by the hindlimbs.  On day 4 and 2 prior to sacrifice, animals 
were injected intraperitoneally with calcein (20 mg/kg) to allow for dynamic histological 
measurements.  On day of sacrifice, animals were euthanized using sodium pentobarbital 
(200 mg/kg, IP).  The distal 2/3 of the right femora were removed, placed in 10%  
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TABLE 1.  STUDY ONE DESIGN 
 
 
 
 
 
 
 
CCAB, cage control + marrow ablated.  HU, hindlimb unloaded; HUAB, hindlimb 
unloaded + marrow ablation on day 0; HU10AB, hindlimb unloading + marrow ablation 
on day 10; AB, marrow ablation.  X denotes group of n = 6-8 animals sacrificed at that 
time point. 
 X BC 
Days 
X X  AB HU HU10AB 
 XXAB+HU HUAB 
X XXXHU HU 
 XXAB CCAB 
24 2014100  
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formalin for 24 hours, and then transferred to 70% ethanol for peripheral quantitative 
computed tomography (pQCT) and histological analyses. 
Study two.  In order to assess the effect of ablation on markers of osteoblast 
differentiation and proliferation, procedures similar to study one were performed with 
groups sacrificed at earlier time points for gene expression analyses.  All animal 
procedures were similar to study one except that no calcein injections were performed.  
Groups (n=6/gp) of CCAB, HUAB and HU10AB animals were sacrificed at 1, 3 and 10 
days post-ablation (see Table 2 for experimental outline).  Baseline controls (BC) were 
sacrificed on day 0 as a comparison group.  These time points were chosen, based on 
previous studies (103,106,108), to assess early and late changes in osteoblast-related 
gene expression.  At sacrifice, the distal 2/3 of right femora were excised, snap frozen in 
liquid nitrogen, and stored at –80◦C for polymerase chain reaction (PCR) analysis.         
Hindlimb unloading.  Unloading of the hindlimbs was achieved by tail suspension with 
minor modifications (3).  Briefly, a wire harness was applied to middle 2/3 of the tail 
using cyanoacrylate.  The tail harness was attached to a metal swivel and then connected 
to a support that spanned the housing cage (5 x 7 x 12”).  The height of the animal’s 
hindlimbs was adjusted to prevent any contact with the cage bottom, resulting in 
approximately a 35 to 40º head-down tilt.  The mouse was able to access about 80% of 
the cage, with traction provided by a wire mesh which covered the cage bottom.   
Marrow ablation.   Animals in select groups underwent right femoral marrow ablation 
as previously described with slight modifications (103,112).  Once the mouse was 
anesthetized, hair was removed from the right hindlimb.  Using aseptic techniques, a 1- 
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TABLE 2.  STUDY TWO DESIGN 
 
 
 
 
 
 
 
 
CCAB, cage control + marrow ablated.  HU, hindlimb unloaded; HUAB, hindlimb 
unloaded + marrow ablation on day 0; HU10AB, hindlimb unloading + marrow ablation 
on day 10; AB, marrow ablation. X denotes group of n = 4-6 animals sacrificed at that 
time point. 
      X BC 
Days 
X 
 
X 
 
11
X 
 
X 
 
13 
X AB   HU HU10AB 
 X X X AB+HU HUAB 
X X X X HU HU 
 X X X AB CCAB 
201031 0  
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inch incision through the skin was made on the anterior leg across the knee joint and, 
using the distal femoral condyles as a landmark, a 25 gauge needle was inserted into the 
mid-condylar notch.  The needle was removed and a 25 gauge dental drill inserted into 
the same hole, rotated clockwise/counterclockwise several times, and then removed.  A 
27 gauge needle attached to a 3 mL syringe filled with 1.5 mL sterile water was inserted 
and the marrow cavity back-flushed, extruding the marrow.  The needle was removed 
and the open skin wound cleansed using sterile gauze-tipped swabs.  The incision was 
closed using cyanoacrylate and betadyne applied to prevent infection.  Upon recovery, 
animals had full ambulatory capacity.  Animals in HU + ablation groups were unloaded 
as soon as they had recovered from the anesthesia, with an attempt to minimize any 
weightbearing before unloading began.   
Peripheral quantitative computed tomography (pQCT).  Ex vivo scans of the right 
femora were performed using a XCT Research M (Stratec; Norland Corp., Fort 
Atkinson, WI).  This model has a minimum voxel size of 0.07 mm and a scanning beam 
thickness of 0.50 mm and has previously been used successfully to detect differences in 
mouse femora density following marrow ablation (112).  Two slices, located at 3 and 4 
mm proximal to the distal condyle plateau, were scanned at a resolution of 0.07 x 0.07 x 
0.50 mm.  This location was selected to match that of histological assessment of 
metaphyseal bone.  Each of the two slices was analyzed for cancellous bone mineral 
content (BMC) and density (BMD), as well as total and marrow area, with the data 
averaged to get a single value for each bone metaphyseal region.  Total area is defined as 
all area encompassed by the periosteal surface while marrow area is the area within the 
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endocortical surface.  Coefficients of variation for measures of cancellous BMC, BMD, 
total area and marrow area, based on five repeat scans of the same bone with 
repositioning between scans, were ± 2.2, 3.1, 1.7 and 1.3%, respectively. 
Histomorphometry.  Following pQCT, undemineralized right femora were subjected to 
dehydration using graded ethanols followed by xylene, and finally embedded in 
methylmethacrylate.  Serial longitudinal sections (4 µm) were cut using a motorized 
rotary microtome (HM355, Carl Zeiss; Thornwood, NY) and affixed to slides.  For each 
bone, one slide was left unstained for fluorochrome label measurements while another 
was processed with the Von Kossa staining procedure for cellular measures.  All 
histological analyses were performed using BioQuant TrueColor Windows image 
processing analysis system (R&M Biometrics, BQTCW98, Version 3.50.6) interfaced 
with a light microscope (Olympus, Leeds Instruments, Irving, TX).     
Dynamic histomorphometry data were collected on unstained sections under 
epifluorescent light.  Briefly, a 1.5-2 mm2 region of interest, located approximately 0.5 
mm distal to the growth plate, was defined at 40x magnification.  Within the defined 
area, single (sLS) and double (dLS) labeled surfaces were measured at 100x while inter-
label widths were measured at 200x.  Calculated variables based on raw data measures 
included:  mineral apposition rate (MAR, µm/d), calculated by dividing the inter-label 
width by the time between labels (2 days); percent mineralizing surface (MS/BS, %), 
calculated using the formula [((sLS/2) + dLS)/total bone surface]*100; and bone 
formation rate (BFR, mcm3/mcm2/day), calculated as (MAR * MS/BS).  All measures 
and variables conform to recommended bone histomorphometry standards (113). 
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Static cell surface histomorphometry data were collected on stained sections with 
the region of study similar to that of dynamic analyses.  Bone volume (BV/TV, %) and 
bone surface (BS) were assessed at 40x magnification while osteoblast and osteoid 
surface, measured at 200x magnification, were combined and presented as a percent of 
total bone surface (Ob.S).  Osteoblasts were defined as single nuclei cuboidal cells lining 
a cancellous bone surface while osteoid was identified by its light blue staining pattern.      
Real-time PCR.  Femora, stored at –80°C, were homogenized using a freezer mill 
(SPEX CertiPrep, Inc, Metuchen, NJ) and total RNA isolated using RNA-STAT 60 (Tel-
Test, Inc., Friendswood, TX), according to the manufacturer’s protocol.  Levels of 
steady state mRNA for osteocalcin (OC) and core binding factor 1 (cbfa1) were 
determined by quantitative real-time RT-PCR.  Denatured total RNA from the bone 
samples (1 µg) was reverse-transcribed to cDNA using TaqMan Reverse Transcription 
Reagent (Applied Biosystems, Foster City, CA) in a 20µL reaction.  Oligonucleotide 
primers and TaqMan probes for PCR amplification were designed (Table 3) based on 
murine sequences using Primer Express software (Version 1.0) and synthesized with a 
FAM reporter fluorescent dye using Assay-by-Design service (Applied Biosystems, 
Foster City, CA).  After reverse transcription, 2µL cDNA was amplified and quantified 
using the ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Foster 
City, CA) according to manufacturer’s protocol.  All samples were performed in 
duplicate with expression levels normalized to 18S RNA from the same sample, 
simultaneously amplified under similar conditions (30 min at 48°C, 10 min at 95°C, 40 
cycles of 15 sec at 95°C and 1 min at 60°C).  Fluorescence data collected during PCR  
  35  
TABLE 3:  OLIGONUCLEOTIDE PRIMERS AND TAQMAN PROBES FOR CDNA PCR 
AMPLIFICATION  
 
 
 
 
 
 
 
 
 
 
Cbfa1, core binding factor 1; OC, osteocalcin 
CCGGGTTCATTTCT 
TCCAAGAGGGCAAAAGAAGAGA 
CGTCTTGATTTGCTAATTCTGATTCA 
 
 
Applied Biosystems, Part No, 4308329  
TGAGACCTTCAGGAGGGTAGTTACC 
GCTGCGCTCTGTCTCTCTGA
Sequence (5’ to 3’) 
OC TaqMan probe 
OC forward primer 
OC reverse primer 
18S TaqMan probe 
18S reverse primer 
18S forward primer 
Cbfa1 reverse primer 
Cbfa1 forward primer 
CCATCTTTGGGAAACTACbfa1 TaqMan probe 
Oligonucleotide 
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were analyzed using ABI-Prism software and reported as expression relative to baseline 
control levels, as previously described (114). 
Statistical analyses.  All statistical analyses were performed using SAS software 
(Version 6.12).  Percent change in body mass was assessed using two-way analysis of 
variance (ANOVA) on data combined from both studies.  Skeletal parameters from 
study one were evaluated using specific group comparisons determined a priori to assess 
1) the effect of unloading, 2) the effect of ablation in unloaded compared to 
weightbearing controls and 3) the effect of ablation timing on the response in unloaded 
animals. The independent effect of unloading was assessed by one-way ANOVA using 
baseline control and the four HU groups, with significant main effects tested for group 
differences using Duncan post-hoc analyses.  The effect of ablation in unloaded vs. 
weightbearing controls was assessed with three-way ANOVA on load (CC or HU), 
treatment (ablation or non-ablation) and time (10 or 14 days) using right (ablated) leg 
values from baseline controls, CCAB, HU and HUAB groups.  As no significant 
interaction existed between time and treatment/load for any parameter, data were pooled 
across days and two-way ANOVA analyses were performed to define load and treatment 
effects, with Duncan post-hoc tests used if significant interactions existed.  To assess the 
effect of ablation timing in unloaded animals, ablated limbs of HUAB, HU10AB and 
time-matched HU non-ablated controls were pooled across post-ablation day (10 and 14) 
and assessed using a two-way ANOVA of treatment (ablation or non-ablation) and day 
of ablation (0 or 10 days HU).  Relative expression levels of mRNA from study two 
were analyzed by two-way ANOVA on treatment (HU, CCAB and HUAB) and time (1, 
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3 and 10) using Bonferroni post-hoc tests.   Statistical power for all reported analyses 
was ~ 0.80 unless otherwise noted.  All values are reported as mean ± SE and a p value < 
0.05 was used to determine statistical significance, while differences of p < 0.10 are 
noted in the text as trends.   
Results 
Body mass effects of unloading:   All groups had similar body masses at baseline.  
There was no difference between HUAB and HU10AB body mass changes compared to 
HU at any time point, thus all HU animals were pooled within time across studies one 
and two (data not shown).  There was a significant difference, albeit minimal (< 3%) in 
percent body mass change from baseline compared to time-matched controls at all time 
points through day 14 (Figure 2).   
Skeletal effects of unloading.    Hindlimb unloading did not result in significant changes 
in distal femoral metaphysis cancellous bone mineral content (BMC) or density (BMD) 
at any time point up to 24 days (Table 4).  Cancellous bone volume (BV/TV) and 
percent osteoblast/osteoid surface (Ob.S) were both significantly lower than baseline 
controls by day 14 (-31 and -45%, respectively) remaining lower through day 24.  There 
was no significant effect of unloading on marrow area, percent mineralizing surface 
(MS/BS), mineral apposition rate (MAR) or bone formation rate (BFR).   
Unloading effects on ablation-induced bone formation.  Marrow ablation resulted in 
significantly higher cancellous BMD in both control and unloaded animals (CCAB: 472 
± 6; HUAB: 456 ± 15 mg/cm3) compared to non-ablated controls (BC: 280 ± 8; HU: 262 
± 10 mg/cm3) (Figure 3A-B and 4A).  There was no difference between the ablated  
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TABLE 4.  EFFECTS OF UNLOADING ON DISTAL FEMUR SKELETAL PARAMETERS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distal femoral metaphysis parameters assessed by peripheral quantitative computed 
tomography (BMC, BMD, % marrow area) and histology (all others).  Data are mean ± 
SE with n = 6-8 per group. BMC, bone mineral content; BMD, bone mineral density; 
BV/TV, bone volume per tissue volume; Ob.S, osteoblast surface expressed as percent 
of total bone surface; MS/BS, mineralizing surface per total bone surface; MAR, mineral 
apposition rate; BFR, bone formation rate. Marrow area denotes area within the 
endocortical surface.   All data refer to cancellous bone.  * denotes significant difference 
vs. baseline controls (0-d HU) (p < 0.05). 
1.03 ±  
0.08 
0.96 ±  
0.06 
0.89 ±  
0.07 
0.86 ±  
0.04 
0.99 ± 
0.09 
Marrow area, mm2 
 
0.27 ±  
0.02 
0.27 ±  
0.03 
0.24 ±  
0.02 
0.24 ±  
0.01 
0.29 ± 
0.03 
BMC, mg/mm 
47 ±  
8 
47 ±  
10  
36 ±  
18
34 ±  
10 
55 ±  
11  
BFR, µm3/µm2/day 
 
1.8 ±  
0.1 
1.9 ±  
0.1 
1.6 ±  
0.5 
1.7 ±  
0.2 
2.1 ± 
0.1 
MAR, µm/day 
24 ±  
4 
22 ±  
4 
17 ±  
8 
18 ±  
4 
25 ±  
4 
MS/BS, % 
1.5 ±  
0.4 * 
1.7 ±  
0.3 
1.6 ±  
0.2 * 
1.7 ±  
0.7 
3.1 ± 
0.7 
Ob. S, % 
7.3 ±  
1.1 * 
6.0 ±  
0.57 * 
7.5 ±  
1.1 * 
8.6 ±  
1.0 
10.9 ± 
1.0 
BV/TV, % 
256 ±  
13 
268 ±  
16 
275 ±  
20 
276 ±  
8 
280 ± 
19 
BMD, mg/cm3 
24 20 14 10 0  
Days of hindlimb unloading  
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FIG. 2.  Effect of unloading on body mass changes of skeletally mature C3H mice.  
Hindlimb unloaded data are pooled from both non-ablated and ablated animals as there 
was no significant effect of ablation on body mass changes.  * denotes significant 
difference (p < 0.05) vs. time-matched cage control animals. 
 
Days
0d 1d 3d 10d 13d 14d 20d 24d
Bo
dy
 m
as
s,
 %
 c
ha
ng
e 
fro
m
 b
as
el
in
e
-4
-3
-2
-1
0
1
2
Con
Hind
Control
Hindlimb Unloaded
*
*
* *
  40  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 3.  Images of ablation-induced increases in cancellous bone.  Distal femur 
metaphyses images of non-ablated control (A,C) and 10 days post-ablation (B,D) from 
peripheral quantitative computed tomography (pQCT; A-B) and histology (C-D).  pQCT 
images were obtained at 3.0 mm from the distal femoral plateau using a scanning 
resolution of 0.07 x 0.07 x 0.50 mm.  Histological sections (4 µm) were stained using the 
Von Kossa protocol and imaged at a magnification of 40X.   
A B
DC
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Figure 4:  Ablation-induced changes in cancellous bone density and volume in loaded 
and unloaded animals.  Cancellous bone mineral density assessed by peripheral 
quantitative computed tomography (A) and bone volume assessed by histology (B).    
Ablated limb data represent values pooled from 10 and 14 day post-ablation.  Pooled 
group n’s = 12-16.  BMD, bone mineral density; BV/TV, bone volume per tissue 
volume.  * denotes p < 0.05 vs. non-ablated control within group. 
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limb BMD values in CCAB and HUAB mice.  Cancellous BMC was also significantly 
higher while marrow area was significantly lower in both loaded and unloaded ablated 
animals compared to non-ablated controls (Table 5); total area inside the periosteal 
perimeter was not different among groups. 
Ablated limb cancellous BV/TV was significantly higher than non-ablated values 
in both control (BC: 10.9 ± 0.7; CCAB: 14.1 ± 1 %) and unloaded groups (HU: 8.1 ± 
0.8; HUAB: 14.4 ± 1.1 %) with no interaction between ablation and loading (Figure 3C-
D and 4B).  Percent osteoblast surface (BC: 3.13 ± 0.5; CCAB: 7.44 ± 1.0; HU: 1.63 ± 
0.4; HUAB: 6.19 ±1.2 %) and MAR (BC: 2.1 ± 0.1; CCAB: 3.5 ± 0.2; HU: 1.9 ± 0.1 
HUAB: 3.6 ± 0.2 µm/day) were similarly higher in ablated control and unloaded animals 
as compared to the non-ablated groups (Figure 5A, 5C). There was no interaction of 
ablation and loading.  Percent mineralizing surface (MS/BS) was significantly 
influenced by load, with unloaded animals having lower values compared to controls 
(Figure 5B); there was no significant effect of ablation in either group.  There was a 
significant interaction between ablation and load with respect to bone formation rate 
(BFR).  Ablated limb BFR in CCAB animals (102 ± 12 µm3/µm2/day) was nearly two-
fold higher compared to that in non-ablated controls (55 ± 7 µm3/µm2/day) while there 
was no difference between non-ablated HU and HUAB animals (38 ± 9 and 47 ± 8 
µm3/µm2/day, respectively)   (Figure 5D).  Additionally, CCAB values were 
significantly higher than those of HUAB animals. 
Results from study two document that cbfa1 mRNA expression, relative to 
baseline controls, was significantly reduced at day 1 and 3 after marrow ablation with no  
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TABLE 5:  EFFECT OF UNLOADING AND ABLATION ON PQCT PARAMETERS   
 
 
 
 
 
 
 
 
Distal femoral metaphysis parameters assessed by peripheral quantitative computed 
tomography (pQCT).  Data are mean ± SE of  n = 12-16 animals per group,  pooled from 
10 and 14 day post-ablation time points. AB, marrow ablation;  BMC, bone mineral 
content. Total area denotes all area encompassed by periosteal surface.  Marrow area 
denotes area within the endocortical surface.  * denotes significant main effect of 
ablation compared to non-ablated (p < 0.05). 
2.40 ±  
0.06 
2.20 ±  
0.05 
2.40 ±  
0.08 
2.36 ±  
0.12 
Total area, mm2 
0.76 ±  
0.04 * 
0.87 ±  
0.04 
0.76 ±  
0.02 * 
0.99 ±  
0.06 
Marrow area, mm2 
 
0.33 ±  
0.02 * 
 
0.24 ±  
0.01 
 
0.36 ±  
0.01 * 
 
0.29 ±  
0.02 
 
BMC, mg/mm 
AB Control AB Control  
Unloaded Control 
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Figure 5:  Ablation-induced changes in osteoblast related parameters in loaded and 
unloaded animals.  Histologically assessed osteoblast surface (A), mineralizing surface 
(B), mineral apposition rate (C) and bone formation rate (D).  Ablated limb data 
represent values pooled from 10 and 14 day post-ablation (total n = 12-16).  All data 
refer to cancellous bone.  * denotes p < 0.05 compared to non-ablated control within 
group. # denotes p < 0.05 vs. ablated unloaded value. † denotes p < 0.05 vs. unloaded 
when ablated and non-ablated groups are pooled.
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interaction of time and treatment (Figure 6A).  Osteocalcin mRNA expression was 
unchanged compared to baseline at time points measured (Figure 6B). 
Effect of prior unloading on response to ablation.  Cancellous BMC, BMD, BV/TV 
and MAR were significantly higher, while MS/BS and marrow area were significantly 
lower, in ablated bones compared to non-ablated controls (Table 6).  There was no 
difference between HUAB and HU10AB groups for these parameters.  While Ob.S was 
significantly increased in both HUAB and HU10AB ablated limbs with respect to non-
ablated animals, the magnitude of this response to ablation was different with respect to 
the timing of ablation (Figure 7).  HUAB ablated limbs had a significantly greater Ob.S 
(6.19 ± 1.2 %) compared to HU10AB ablated limbs (3.95 ± 0.4 %).  BFR values were 
not different among the groups (Table 6). Results from study two revealed that 
unloading prior to ablation (HU10AB groups) did not have a significant effect on 
relative expression of steady state cbfa1 and osteocalcin mRNA at any post-ablation 
time point as compared to HUAB (Table 7). 
Discussion 
The data presented herein document that weightbearing is not necessary for 
ablation-induced increases of osteogenic activity (e.g. bone volume and osteoblast 
surface).  These similar increases in select osteoblast-related parameters exist despite the 
independent negative effects of hindlimb unloading in these skeletally mature C3H male 
mice.  The absence of mechanical load does, however, significantly influence the 
mineralization of newly formed bone, suggesting that this last phase of new bone 
formation may be limiting during periods of disuse.  In addition, when osteoblast  
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TABLE 6:  INFLUENCE OF ABLATION TIMING ON RESPONSE IN UNLOADED BONE 
 
  
 
 
 
 
 
 
 
 
 
 
 
Distal femoral metaphysis parameters assessed by peripheral quantitative computed 
tomography (BMC/BMD) and histology (all others).  Data are mean ± SE of  n = 12-16 
animals per group,  pooled from 10 and 14 day post-ablation time points.  HUAB, 
hindlimb unloaded with marrow ablation on day 0; HU10AB, hindlimb unloaded with 
marrow ablation after 10 days.   BMC, bone mineral content; BMD, bone mineral 
density; BV/TV, bone volume per tissue volume; MS/BS, mineralizing surface per bone 
surface; MAR, mineral apposition rate; BFR, bone formation rate. Marrow area defined 
as area within the endocortical surface.  All data refer to cancellous bone.  * denotes 
overall significant effect of ablation compared to non-ablated (p < 0.05). # denotes 
significantly different from non-ablated HUAB control (p < 0.05). 
456 ±  
15 * 
262 ±  
10 
443 ±  
11 * 
276 ±  
10 
BMD, mg/cm3 
 
0.37 ±  
0.02 * 
 
0.27 ±  
0.02 
 
0.33 ±  
0.02 * 
 
0.24 ±  
0.01 
 
BMC, mg/mm 
65 ±  
8 
47 ±  
6 
47 ±  
8 
38 ±  
9 
BFR, µm3/µm2/day 
3.4 ±  
0.2* 
1.9 ±  
0.1 
3.6 ±  
0.2 * 
1.9 ±  
0.1 
MAR, µm/day 
20 ±  
8 * 
23 ±  
2 
13 ±  
2 * 
19 ±  
4 
MS/BS, % 
12.9 ±  
1.3 * 
6.6 ±  
0.6 
14.4 ±  
1.1 * 
8.1 ±  
0.7 
BV/TV, % 
0.83 ±  
0.04 * 
0.99 ±  
0.05 # 
0.76 ±  
0.04 * 
0.87 ±  
0.04 
Marrow area, mm2 
AB Control AB Control  
HU10AB HUAB  
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TABLE 7:  RELATIVE MRNA EXPRESSION IN UNLOADED ABLATED ANIMALS  
 
 
 
 
 
 
 
 
 
 
Ablation-induced changes in steady state core binding factor 1 (cbfa1) and osteocalcin 
(OC) mRNA expression in study 2 animals sacrificed 1, 3, or 10 days after ablation.  
Total RNA (1µg) from isolated femora (n=4-6/gp) was reverse transcribed to cDNA and 
then amplified using real time PCR.  Amplification was normalized to 18S RNA and 
values are expressed relative to BC expression levels.  HUAB, hindlimb unloaded + 
marrow ablation on day 0; HU10AB, hindlimb unloaded for 10 days prior to marrow 
ablation. 
HU10AB HUAB 
0.35 ± 
0.12 
 
0.43 ±
 0.29 
3
1.00 ± 
0.54 
 
0.63 ± 
0.28 
10
0.86 ± 
0.29 
0.40 ±  
0.11 
1.80 ± 
0.78 
0.65 ± 
0.27 
OC, relative 
expression 
 
4.2 ± 
3.8 
 
0.11 ±  
0.03 
 
0.55 ± 
0.22 
 
0.50 ± 
0.27 
 
Cbfa1, relative 
expression 
103 11  
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FIG. 6.  Ablation-induced changes in steady state cbfa1 and osteocalcin mRNA 
expression.  Study 2 animals sacrificed 1, 3, or 10 days after ablation.  Total RNA (1µg) 
from isolated femora (n=4-6/gp) was reverse transcribed to cDNA and then amplified 
using real time PCR for cbfa1 (A) and osteocalcin (B).  Amplification was normalized to 
18S RNA and values are expressed relative to BC levels.  † denotes p < 0.05 vs. baseline 
control when all groups in time are pooled. 
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FIG. 7.  Influence of ablation timing on osteoblast number in unloaded bone.  Ablated 
limb data represent values pooled from 10 and 14 day post-ablation (total n’s = 12-16).  
HUAB, hindlimb unloaded with marrow ablation on day 0; HU10AB, hindlimb 
unloaded with marrow ablation after 10 days.  * denotes p < 0.05 vs. non-ablated control 
within group.  # denotes p < 0.05 vs. ablated unloaded value.
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functionality was reduced prior to ablation, the amount of osteoblast forming surface 
was reduced, along with the amount of mineralization.  Collectively, these data 
document normal ablation-induced increases of cancellous bone volume even in the 
absence of mechanical loading.  However, differences in the extent of actively 
mineralizing surface suggest that mineralization deficits are a major contributor to bone 
formation limitations during disuse. 
In response to hindlimb unloading (without ablation), the skeletally mature C3H 
male mouse experienced significant reductions in cancellous bone volume and percent 
osteoblast surface.  These changes occurred despite no significant change in cancellous 
BMD (by pQCT), percent mineralizing surface, mineral apposition rate and bone 
formation rate, although all statistical analyses had less than optimal power due to the 
large number of groups.  As no study to date has assessed changes in unloaded mice 
using pQCT, it is not clear if the lack of cancellous BMD change with unloading is 
unique to the C3H strain, known for its high bone density (92), or if the resolution of 
pQCT scans (70µm) was not adequate to detect subtle changes in cancellous BMD of 
mice after this period of unloading.   
Histological assessments of murine cancellous bone changes with unloading have 
only recently been performed using skeletally mature C3H mice (97,100).  After 14 days 
of unloading proximal tibia cancellous bone volume in female C3H mice is lower than in 
controls (-31%)(100), quantitatively similar to changes observed in the distal femur 
metaphysis in the current study (-31% after 24 days).  However, in male C3H mice no 
change in femoral cancellous bone volume after 14 and 21 days of unloading is noted 
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(97).  Mineral apposition and bone formation rates do not change (female C3H)(100) or 
increase (male C3H)(97) compared to weightbearing controls; neither study quantified 
percent osteoblast surface, a variable sensitive to unloading in the current study.  
These previous results, combined with the current data, suggest only a transient 
decrease in dynamic bone formation parameters in the skeletally mature C3H mouse 
with unloading.  The explanation for this is unclear.  Previous data suggest C3H mice 
may be insensitive to mechanical load perturbations, as they exhibit no increase in 
cortical bone formation rate compared to other strains in response to mechanical loading 
(115, 116).  This theory does not appear to apply to cancellous bone in the current study.  
Significant changes with unloading are noted in select dynamic parameters when data 
are pooled from ablated and non-ablated animals, thus increasing the subject number and 
therefore the power of the analysis.  However, the changes appear to be transient with 
respect to these dynamic parameters.  Similar transient decrease in mineral apposition 
and bone formation rates have previously been noted when young, skeletally immature 
rats are unloaded (71).  Thus, whether these transient decrements in dynamic cancellous 
properties of C3H mice are due to a lack of skeletal maturity at 4 months of age, a partial 
resistance to altered mechanical load, or some other factor necessitates more detailed 
study. 
Marrow ablation, a potent bone formation stimulus, resulted in significantly 
higher distal femur metaphysis cancellous BMC, BMD and bone volume in both 
weightbearing and unloaded animals.  Ablation-induced increases in femoral metaphysis 
bone volume have previously been quantified in weightbearing animals using microCT 
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(109,117) and histology (105,106).  These are the first data to document that these 
responses will occur even in the absence of mechanical loading.  The ablation-induced 
increase in pQCT-measured BMD, calculated as bone mineral content per unit marrow 
area (within the endocortical perimeter), could be accounted for by 1) an increased 
volume of cancellous tissue; 2) an increased density of pre-existing cancellous tissue; 3) 
minimal change in cancellous tissue and/or density with a concomitant decrease in 
marrow area or 4) a combination of all three processes.  As bone mineral content within 
the marrow cavity was significantly increased (+35%), similar in magnitude to the 
increase in histologically measured bone volume (BV/TV, +33%), it is clear that 
ablation results in an increased volume of cancellous tissue.  However, a significant 
decrease in marrow area was also quantified (+ 18%) suggesting that some combination 
of these two changes accounts for the increase in ablated animal BMD.  One additional 
factor potentially contributing to increase density is the degree of tissue mineralization, a 
variable not directly quantifiable by pQCT.   Thus, it is possible that subtle differences 
exist in the contribution of changes in bone volume, area and unmeasured parameters, 
such as tissue mineralization, between loaded and unloaded ablated animals.  
Although unloading did not significantly reduce percent mineralizing surface in 
the analysis of HU only animals, there was a significant overall effect of unloading (-
40%) when ablated and non-ablated limb data were pooled.  This discrepancy is likely 
due to the low power of the HU only analysis.   Previous studies have documented 
mineralization deficits of cortical bone formed during unloading (71,74) and spaceflight 
(118) in young rats, as well as during fracture healing in space-flown and hindlimb 
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unloaded rats (119).  Only indirect evidence exists with respect to alterations of 
cancellous bone mineralization with unloading (120).  Yet, as unloading results in highly 
unorganized collagen matrix (121), and this matrix directly facilitates mineralization 
(122), it seems reasonable to speculate that the woven bone formed in response to 
ablation is altered with unloading.  While these deficits in mineralization must be 
confirmed through further study, the potential implications are significant with respect to 
compromised strength of bone formed during disuse. 
Reductions of cancellous bone mineralizing surface in unloaded ablated mice 
were consistently coupled with an increased mineral apposition rates (MAR).  Changes 
in MAR can be somewhat misleading, as this variable yields no information about the 
extent of surfaces with double labeling.  Therefore, percent mineralizing surface and 
percent osteoblast surface provide a more global view of activity across all cancellous 
bone surfaces.  Yet, these two parameters do not change in tandem, as ablation produced 
significant increases in percent osteoblast surface in both loaded and unloaded animals 
with no effect of ablation on mineralizing surface in either ablated group compared to 
non-ablated controls.  While there is undoubtedly some temporal relationship between 
mineralizing and osteoblast surface, the discrepancy between these variables in unloaded 
ablated animals suggests a potential osteoblast dysfunction.  Osteoblasts cultured in the 
absence of gravity exhibit reduced functionality (13) and increased apoptosis (123).  
Thus, osteoblasts covering cancellous bone surfaces in unloaded ablated bones may have 
had altered functionality (e.g. produced un-mineralizable matrix) or had increased rates 
of apoptosis, accounting for the discrepancy of osteoblast and mineralizing surfaces.  It 
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can not be discounted; however, that mineralization may simply be delayed in unloaded 
animals. 
The paradoxical lack of BFR increase in unloaded ablated bones, despite a 
significant increase in cancellous bone volume, is difficult to explain.  Neither measure 
assesses the degree to which the bone that is present is mineralized, while measures of 
bone volume require only a minimal mineralization level to be detected.  Hence, if under 
mineralized bone is present in unloaded animals, as suggested by pQCT results, it is 
possible that no increase in bone formation rate will be detected, as fluorochrome labels 
are only deposited on actively mineralizing surface.  It should also be noted that dynamic 
measures assess only the activity within the final week before animal sacrifice; thus, 
bone formation may have been higher in unloaded ablated animals at earlier time points 
post-ablation before declining by the last week of the experiment.      
Due to the effect of unloading and ablation on osteoblasts, mRNA levels of two 
osteoblast-specific markers, core binding factor 1 (cbfa1) and osteocalcin (OC) were 
assessed using real time PCR in an attempt to elucidate mechanisms of altered osteoblast 
functionality.  This technique measures fluorescence emitted from amplicon-specific 
probes during cDNA amplification, normalized to an endogenous control (18S) 
amplified under identical conditions in order to account for differences in total RNA 
added to each reaction.  Real time PCR provides certain advantages over traditional 
PCR, such as the ability to detect changes during the exponential growth phase rather 
then at the end of amplification, thus increasing the sensitivity of detection (124).   
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In the present study, there was a significant decrease in the expression of cbfa1 
mRNA at days one and three with no difference among groups, suggesting that both 
unloading and ablation result in similar reductions of osteoblast differentiation signals. 
The fact that lower cbfa1 mRNA levels do not coincide with declines in percent 
osteoblast surface, at least on ablated cancellous bone surfaces, suggest that fully 
differentiated osteoblasts may be recruited to the marrow cavity in response to ablation.  
Thus, rather than relying on differentiation and proliferation of locally available 
osteoblast progenitors, ablation may signal peripheral osteoblasts to migrate to the area 
due to the need to produce cancellous bone very rapidly.  It is also possible that changes 
in marrow cbfa1 mRNA expression were not detectable when whole bone samples were 
analyzed, which included bone as well as marrow.  Gene expression analysis of marrow 
extracts may have provided different results yet separating out marrow tissue from 
ablated bones poses numerous problems and difficulties.   
Neither ablation nor unloading significantly altered osteocalcin mRNA 
expression in the current study suggesting no change in functional activity of mature 
osteoblasts.  Similar to cbfa1, these data contradict histological assessment of percent 
osteoblast cancellous bone surface yet lend support to the speculation regarding 
dysfunctional osteoblasts with ablation.  Furthermore, the data obtained from PCR 
analysis provides information on only mRNA expression, one step in the process of 
producing proteins.  Thus alterations in osteocalcin protein, the functional product, may 
be altered despite no effect on mRNA expression. 
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When marrow ablation was performed after a period of unloading of sufficient 
duration to suppress select cancellous bone parameters before ablation, BMC, BMD, 
bone volume and mineral apposition rate values elevated as much as those in mice 
unloaded on the day of ablation.  Mineralizing surface of unloaded animals (independent 
of when ablation occurred) is significantly lower compared to non-ablated unloaded 
animals.  When mineralizing surface data are combined with mineral apposition rate, no 
difference was noted among groups with respect to the rate of bone formation.  These 
data are consistent with earlier speculation about reduced mineralization in unloaded 
bone, and document a further reduction in actively mineralizing surface when ablation 
occurs in bone already experiencing mechanical unloading.  The most sensitive 
parameter to unloading appears to be percent osteoblast surface, as the significant 
increase in this parameter in HUAB animals is attenuated when bone is unloaded for ten 
days prior to ablation (HU10AB).  This suggests a disruption in the responsiveness to 
anabolic stimuli if applied to bone that has been compromised by unloading.  The 
potential implications of these results are substantial, as they suggest that 
countermeasures aimed at maintaining osteoblast function during disuse must be 
initiated very soon after disuse begins.  Significant delays may compromise the efficacy 
of the intervention in terms of stimulating osteoblast function.   
Although the series of osteogenic events following ablation are accelerated in 
comparison to those induced by other mechanical and pharmacological stimuli, as well 
as during de novo bone formation, the sequence of cellular events are all similar.  These 
include increases of osteoblast surface, mineral apposition rate and bone formation rate, 
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eventually leading to increased bone volume.  The main differences with respect to the 
marrow ablation model are the rapidity of the response.  This unique characteristic 
allows the assessment of limitations in osteoblast function in an acute timeframe.  
Reductions of mineralization in unloaded animals have been previously documented 
using the fracture healing model, another extreme bone formation stimulus (119).  
Together, these results suggest impaired mineralization of newly formed cancellous bone 
in the absence of mechanical loading.  As both marrow ablation and fracture healing are 
powerful stimuli, potentially effecting osteoblast/mineralization via unique mechanisms, 
these results should be confirmed using less potent bone formation stimuli such as 
mechanical loading or intermittent parathyroid hormone (PTH) treatment.     
In conclusion, these data suggest subtle yet significant effects of unloading on the 
response to marrow ablation, providing insight into limitations of bone formation in the 
absence of mechanical load.  The unique effect of unloading is with respect to a 
reduction in mineralizing surface, leading to an attenuation of the bone formation rate 
increase noted in weightbearing controls.  This suggests that the limitations of bone 
formation with unloading are the result of altered osteoblast products (e.g. osteoid) 
rather than in the inability of osteoblasts to be recruited or develop normally.  The 
caveat, however, is that when bone formation is stimulated after a period of unloading 
sufficient to compromise osteoblast functionality, increases in osteoblast recruitment to 
the bone surface are compromised. 
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CHAPTER IV 
SUMMARY AND FUTURE RESEARCH 
 The goal of this project was to begin identifying the mechanisms responsible for 
decreased bone formation during disuse.  To do so, the potent bone formation stimulus 
of marrow ablation was superimposed on hindlimb unloaded mice to elucidate if the 
ablation-induced response would occur under conditions that normally reduce osteoblast 
activity.  These data document that ablation-induced cancellous bone exhibits 
mineralization deficits resulting in a failure to increase bone formation rate.  The 
potential implication of this mineralization deficit is that bone produced in the absence 
of loading would have lower overall strength.  This would increase the subsequent risk 
of fracture, especially upon the return to normal loading.  Additionally, the degree of 
osteoblast response is sensitive to osteoblast functionality at the time of ablation.  This 
finding significantly impacts on countermeasure initiation.  If bone formation 
stimulation protocols are delayed for a period of time after disuse begins, the efficacy 
will be compromised.   
While these results provide support for deficits in cancellous bone mineralization 
in the absence of mechanical load, many questions remain.  Future studies should focus 
on confirming these results using 1) alternative bone formation stimuli, 2) a larger 
animal model, and 3) additional techniques.   
The extreme nature of the marrow ablation stimulus may not have allowed the 
detection of subtle differences with respect to bone formation parameters between 
weightbearing and unloaded animals.  As such, other stimuli, such as pharmacological 
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doses of intermittent PTH , FGF, or mechanical loading may provide additional 
information with respect to limitations of osteoblasts in unloaded bone.  Although the 
mouse provides many advantages in research, there are also notable disadvantages.  Due 
to the distinct differences in skeletal phenotypes and responses to manipulation, the 
responses documented herein can not be generalized beyond the C3H strain.  The size of 
mouse bones also is prohibitive with respect to more in-depth analyses of 
osteoprogenitor cells confined to the marrow.  For these reasons, the use of rats may be 
advantageous although there are also disadvantages using this species such as the longer 
timeframe to reduce osteoblast functionality (~ 21 days).  Finally, additional techniques 
should be used to further investigate limitations in mineralization with unloading.  This 
is probably most easily accomplished through culture of the ablated limb bone marrow at 
various time points following ablation, focusing specifically on mineralization outcomes.  
Based on these cell culture results further analyses could focus on specific factors 
(genes, transcription factors, cytokines, hormones) which contribute to the decrements in 
mineralization.  Techniques in addition to cell culture may include imagining methods 
such as quantitative backscattered electron imaging, synchrotron radiation 
microtomography, scanning small angle X-ray scattering, Fourier transform infrared 
microspectroscopy, and Raman spectroscopy.  These methods provide data on the degree 
of mineralization in discrete bone regions as well as mineral structure and composition, 
therefore potentially providing a means to more completely assess how mineralization is 
altered in the absence of mechanical loads. 
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31:1 149-57. 
 
MR Allen and SA Bloomfield.  Cancellous bone maintenance following long-
term hindlimb unloading in skeletally mature female rats.  J Appl Physiol 94: 
642-650, 2003. 
 
XD Chen, MR Allen, S Bloomfield, T Xu, and M Young.  Biglycan Deficient 
Mice Have Delayed Osteogenesis after Marrow Ablation.  CTI (In press 2003). 
 
AWARDS AND HONORS 
 
Texas ACSM Doctoral Poster Award (2nd place), 2002 
Sun Valley Hard Tissue Workshop Young Investigator Travel Award, 2001 
Texas ACSM Manuscript Award (2nd place), 2001 
Texas ACSM Doctoral Poster Award (2nd place), 2000 
Texas A&M Student Research Week Biological Science Oral Presentation, 
Doctoral category, 2000 
